|
Analyzing treatment patterns and time to the next treatment in chronic lymphocytic leukemia real-world data using automated temporal phenotyping. |
|
|
|
|
|
|
|
|
|
Stock and Other Ownership Interests - Sema4 |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
|
|
|
|
Stock and Other Ownership Interests - Lilly; Merck; Sema4 |
Travel, Accommodations, Expenses - Sema4 |
|
|
|
|
Stock and Other Ownership Interests - Sema4 |
|
|
|
|
Stock and Other Ownership Interests - Personalis; Sema4 |
Patents, Royalties, Other Intellectual Property - Personalis |
|
|
|
|
Stock and Other Ownership Interests - Sema4 |
|
|
|
Stock and Other Ownership Interests - Sema4 |